XLRN - Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q2 2021 Results - Earnings Call Transcript
Acceleron Pharma Inc. (XLRN) Q2 2021 Earnings Conference Call August 5, 2021 05:00 PM ET Company Participants Jamie Bernard - Associate Director of Investor Relations Habib Dable - Chief Executive Officer Kevin McLaughlin - Chief Financial Officer Jay Backstrom - Head of Research and Development Sujay Kango - Chief Commercial Officer Conference Call Participants Yaron Werber - Cowen Carter Gould - Barclays Anna Baran - SVB Leland Gershell - Oppenheimer Corinne Jenkins - Goldman Sachs Presentation Operator Good afternoon, ladies and gentlemen and welcome to the Acceleron Second Quarter 2021 Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. As a reminder this conference call is being recorded. I would now like to hand the conference over to Ms. Jamie Bernard, Associate Director of Investor Relations at Acceleron. Please go ahead.
For further details see:
Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q2 2021 Results - Earnings Call Transcript